Adriana Gregory
Papers
2
Total Citations
7
H-Index
2
About
Adriana Gregory is a leading researcher in preclinical imaging, with a focused expertise in developing and validating noninvasive techniques for assessing polycystic kidney disease (PKD). Her work centers on the critical need for accurate, high-throughput methods to measure total kidney volume (TKV)—a key biomarker for staging PKD severity. Gregory’s major contribution lies in pioneering the use of robotic 3D ultrasound as a cost-effective, radiation-free alternative to magnetic resonance imaging (MRI) for in vivo rodent studies. Her landmark 2020 paper, "Assessing Polycystic Kidney Disease in Rodents," demonstrated the comparative efficacy of robotic 3D ultrasound against MRI, earning 5 citations and establishing a new standard for preclinical PKD research. In her 2021 follow-up, she provided a detailed protocol for 3D robotic ultrasound analysis, further advancing the field’s accessibility. By bridging the gap between imaging modalities—weighing factors like cost, ease of use, and the avoidance of ionizing radiation—Gregory’s work has significant implications for translational medicine. Her innovations enable more efficient, ethical, and scalable studies, directly supporting the development of therapies for this inherited disorder.
Research Focus
Key Achievements
Top Papers
- 1
- 2